ScholarIQanswers from OpenAlex & ORCID
Anjay Rastogi
ResearcherPublications, citations & collaboration network
Anjay Rastogi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anjay Rastogi have?
ScholarIQindexed works
Anjay Rastogi has 201 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anjay Rastogi have?
ScholarIQcitation count
Anjay Rastogi has 6,503 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anjay Rastogi?
ScholarIQh-index
Anjay Rastogi has an h-index of 38 in OpenAlex.
What is the i10-index of Anjay Rastogi?
ScholarIQi10-index
Anjay Rastogi has an i10-index of 74 in OpenAlex.
What is the ORCID of Anjay Rastogi?
ScholarIQorcid
The ORCID for Anjay Rastogi is on the source record.
What is the OpenAlex record for Anjay Rastogi?
ScholarIQopenalex
The OpenAlex for Anjay Rastogi is on the source record.
What are the most-cited papers on Anjay Rastogi?
ScholarIQmost cited works
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Bevra H. Hahn, Maureen McMahon, Alan Wilkinson, William D. Wallace, David Daikh, John FitzGerald, George Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey‐Goldman, Karandeep Singh, Mazdak A. Khalighi, Soo‐In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, W. J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen, Jennifer M. Grossman
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, George L. Bakris, Ricardo Correa-Rotter, Fan Fan Hou, Dalane W. Kitzman, Donald Kohan, Hirofumi Makino, John J.V. McMurray, Joel Z. Melnick, Michael G. Miller, Pablo E. Pérgola, Vlado Perkovic, Sheldon W. Tobe, Tingting Yi, Melissa Wigderson, Dick de Zeeuw, Alicia Elbert, Augusto Vallejos, Andres Alvarisqueta, Laura Maffei, Luis I. Juncos, Javier de Arteaga, Gustavo Greloni, Eduardo Farias, A Zucchini, Daniel Vogel, Ana María Cusumano, Juan Carlos Santos, Margaret B. Fraenkel, Martin Gallagher, Timothy M. E. Davis, Shamasunder Acharya, Duncan Cooke, Michael Suranyi, Simon D. Roger, Nigel D. Toussaint, Carol A. Pollock, Doris Chan, Stephen Stranks, Richard J. MacIsaac, Zoltán Endre, Alice Schmidt, Rudolf Prager, Gert Mayer, Xavier Warling, Michel Jadoul, Jean Hougardy, Chris Vercammen, Bruno Van Vlem, Pieter Gillard, Adriana Costa e Forti, João Borges, Luis Santos Canani, Freddy G. Eliaschewitz, Silmara Leite, Fadlo Fraige Filho, Raphael Paschoalin, José A. Moura-Neto, Luciane Mônica Deboni, Irene de Lourdes Noronha, Cíntia Cercato, Carlos Alberto Prompt, Maria Teresa Zanella, Nelson Rassi, Domingos O. d’Avila, Rosângela Milagres, João Soares Felício, Roberto Pecoits‐Filho, Miguel C. Riella, João Eduardo Nunes Salles, Elizete Keitel, Sérgio Antônio Draibe, Celso Amodeo, J. T. Youmbissi, Louise Roy, Serge Cournoyer, Shivinder Jolly, Vincent Pichette, Gihad Nesrallah, Harpreet S. Bajaj, Hasnain Khandwala, Ronnie Aronson, Richard Goluch, Paul Kwong Hang Tam, Christian Rabbat, Sheldon W. Tobe, G. HOWARD BAILEY, S. P. Chow, A Castillo, Alfredo Danin Vargas, Fernando González, Rodrigo Muñoz, Vicente Gutiérrez, Gonzalo Godoy, Hongwen Zhao, Zhangsuo Liu, Ming‐Hui Zhao, Xiaohui Guo
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
Fouad T. Chebib, Ronald D. Perrone, Arlene B. Chapman, Neera K. Dahl, Peter C. Harris, Michal Mrug, Reem A. Mustafa, Anjay Rastogi, Terry Watnick, Alan S.L. Yu, Vicente E. Torres
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Andreas L. Birkenfeld, Janet B. McGill, Sylvia E. Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F. Scheerer, George L. Bakris, Rajiv Agarwal, on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Augusto Vallejos, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Richard J. MacIsaac, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon D. Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Peter G. Colman, David Colquhoun, Chris Ellis, Kim Joshua, Eugenia Pedagogos, Paul Regal, Duncan J. Topliss, James Vandeleur, Johan Verjans, Gary Wittert, Katie-Jane Wynne, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer, Bernhard Paulweber, Rudolf Prager, Wolfgang Preiß, Friedrich C. Prischl, G. Schernthaner, Harald Sourij, Martin Wiesholzer, Heinz Drexel, Rainer Oberbauer, Hans‐Robert Schönherr, Peter Doubel, W. Engelen, Pieter Gillard, Jean‐Michel Hougardy, Jean-Marie Krzesinski, Bart Maes, Marijn M. Speeckaert, Koen Stas, Luc Van Gaal, Hilde Vanbelleghem, Francis Duyck, André Scheen, Daniela Antunes, Roberto Botelho, Cláudia Brito, Luís Henrique Santos Canani, Maria Eugênia Fernandes Canziani, Maria Cerqueira, Rogério de Paula, Freddy G. Eliaschewitz, Carlos Eduardo Poli‐de‐Figueiredo, Adriana Costa e Forti, Miguel Nasser Hissa, Maurilo Leite, Emerson de Lima, Irene L. Noronha, Bruno Paolino
Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
Louis Holdstock, Amy M. Meadowcroft, Rayma Maier, Brendan M. Johnson, Delyth Jones, Anjay Rastogi, Steven Zeig, John J. Lepore, Alexander R. Cobitz